NEOG Stock Analysis: Buy, Sell, or Hold?

NEOG - Neogen Corp

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$8.70
-0.45 (-4.92%) ▼
5d: +4.07%
30d: -23.14%
90d: +23.14%
HOLD
MODERATE Confidence
Protect Your NEOG Gains
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 08, 2026 8d
Smart Money Accumulation

NEOG is down 7.5% this week, but smart money is accumulating calls. Top strike: $10 2026-04-17 with 6,117 OI. Call ratio: 100% View Scanner →

Strength: 8.7/10

Get Alerted When NEOG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: NEOG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on -2.7% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NEOG is currently trading at $8.70, which is considered oversold relative to its 30-day fair value range of $9.01 to $11.04. The stock's valuation (Forward PE: 26.9) is in line with its historical norms (27.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, NEOG is in a strong uptrend. Immediate support is located at $8.24, while resistance sits at $9.47. Short-term momentum is weak, with the stock down 4.9% recently.

Market Sentiment: NEOG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.67 (+34.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $9.01 - $11.04
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.4%

Protect Your Profits

Holding NEOG? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.9%)
  • BULLISH: Trading 34.1% below Wall St target ($11.67)

Fair Price Analysis

30-Day Fair Range $9.01 - $11.04
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $8.24
Resistance Level $9.47
Current Trend Strong Uptrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) 26.91
Wall Street Target $11.67 (+34.1%)
Revenue Growth (YoY) -2.8%
Earnings Growth (YoY) -85.6%
Profit Margin -68.5%
Valuation Discount vs History -0.1% cheaper
PE vs Historical 26.9 vs 27.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -0.1% (market-implied from PE analysis)
1-Year Target $8.69 (0%)
2-Year Target $8.68 (0%)
3-Year Target $8.67 (0%)
3-Yr Target (if PE normalizes) (PE: 27→27) $8.70 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 26.9, Growth: -9.4%) $6.48 (+-26%)
Base: (SPY PE: 22.4, Growth: -9.4%) $5.39 (-38%)
Bear: (PE: 19.0, Growth: -9.4%) $4.58 (-47%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 26.9 to 27.0
Stabilization Target: $8.73 (+0.3%)
PE Expansion Potential: +0.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mikheal Nassif BUY 23 shares 2026-02-17
Mikheal Nassif BUY 24 shares 2026-02-02
Mikheal Nassif BUY 25 shares 2026-01-26

Unlock Insider Activity

See real-time buying/selling by company executives for NEOG.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SYK
Stryker Corporation
BUY
32 analysts
$424 56 HOLD
ABT
Abbott Laboratories
BUY
28 analysts
$133 56 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$111 58 HOLD
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$96 53 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$93 58 HOLD

Advanced NEOG Option Strategies

Professional options setups generated by AI based on today's NEOG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NEOG

NEOG Technical Chart NEOG Price Prediction NEOG Earnings Date NEOG Investment Advisor NEOG Fair Price Analyzer NEOG Options Advisor NEOG Options Chain NEOG Options Analysis NEOG Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals